New Torq AMP Alliance Program Debuts with Armis As a Launch Partner to Accelerate Autonomous SecOps
29.7.2025 15:00:00 CEST | Business Wire | Press Release
Armis, the cyber exposure management & security company, today announced it has been selected as a launch partner for the Torq AMP alliance program, designed to drive agentic AI innovation. Armis was chosen due to its leading Cyber Exposure Management Platform, Armis CentrixTM, that seamlessly integrates with Torq’s SecOps platform to empower customers and their SOC/Incident Response teams.
“As the leader in Cyber Exposure Management, Armis is redefining how organizations understand, prioritize, and reduce risk across their entire attack surface,” said Nadir Izrael, CTO and Co-Founder of Armis. “Our AI-driven platform provides unmatched visibility and contextual intelligence across IT, OT, IoT, medical, and cloud assets—empowering security teams to act decisively. That’s why we’re excited to join Torq’s AMP Alliance. The combination of Armis Centrix™ and Torq’s agentic AI delivers a new level of SecOps automation, where detection, enrichment, and response happen in real time, with precision. Together, we’re making autonomous security operations a practical reality for modern enterprises.”
Organizations can achieve a new level of security efficiency and effectiveness by leveraging the powerful synergy between Armis CentrixTM and Torq's automation capabilities. Armis delivers complete asset discovery and real-time threat intelligence, enabling teams to prioritize critical risks across their entire attack surface. Torq enhances this by allowing security professionals to build and deploy robust, automated workflows without scripting, transforming insight into immediate action. This seamless integration accelerates threat response, automates vulnerability remediation, and enforces device compliance, ultimately reducing manual workloads and strengthening an organization's overall risk posture.
“Torq AMP partners include some of the most prestigious and cutting edge cybersecurity companies in the world and we are excited to welcome Armis to the fold,” said Eldad Livni, CINO and Co-Founder, Torq. “Armis is an example of an innovative vendor that delivers solutions with maximum impact as we realize the potential of the autonomous SOC, together. And that means joint offerings that combine cutting edge threat intelligence drawing from the deepest data pools with blazing fast AI-driven response, remediation, and mitigation. Together, Torq and Armis will protect organizations from the ever-expanding spectrum of threats they’re confronted with every second of every day.”
Learn more about Armis’ collaboration with Torq and its wider technology partner ecosystem here.
About Armis
Armis, the cyber exposure management & security company, protects the entire attack surface and manages the organization’s cyber risk exposure in real time. In a rapidly evolving, perimeter-less world Armis ensures that organizations continuously see, protect and manage all critical assets – from the ground to the cloud. Armis secures Fortune 100, 200 and 500 companies as well as national governments, state and local entities to help keep critical infrastructure, economies and society stay safe and secure 24/7. Armis is a privately held company headquartered in California.
About Torq
Torq is transforming cybersecurity with its agentic AI security operations solutions. Torq empowers enterprises to instantly and precisely detect and respond to security events at scale. Torq’s customer base includes major multinational enterprise customers, including Abnormal Security, Armis, Check Point Security, Chipotle Mexican Grill, Inditex (Zara, Bershka, and Pull & Bear), Informatica, PepsiCo, Procter & Gamble, Siemens, Telefonica, Valvoline, and Wiz, as well as Fortune 100 consumer packaged goods, financial, hospitality, and sports apparel companies.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250729258158/en/
Contacts
Media Contacts:
Rebecca Cradick
Vice President, Global Communications
Armis
pr@armis.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press Release
Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On the demand side, with smart meter integration, Predict+ models each meter individually and performs extensive calculations on actual, historical, and average data to acc
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press Release
Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading transformative and meaningful customer experiences. These leading organizations are turning everyday interactions into seamless, cross-channel journeys that deliver meaningful business impact and
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press Release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
Takeda Announces Positive Topline Results from Pivotal Phase 2/3 Clinical Trial of TAK-881 in Primary Immunodeficiency Disease (PID)4.5.2026 14:00:00 CEST | Press Release
Takeda (TSE:4502/NYSE:TAK) today announced that TAK-881-3001, a pivotal Phase 2/3 clinical trial in patients with Primary Immunodeficiency Disease (PID), met its primary endpoint, which demonstrated pharmacokinetic (PK) comparability between the investigational TAK-881 [Immune Globulin Subcutaneous (Human), 20% Solution (SCIG 20%) with Recombinant Human Hyaluronidase] and HYQVIA [Immune Globulin Infusion (Human) 10% with Recombinant Human Hyaluronidase]. Additionally, secondary endpoints showed that TAK-881, a SCIG 20% facilitated with hyaluronidase, demonstrated safety, efficacy and tolerability profiles comparable to HYQVIA, an established SCIG 10% facilitated with hyaluronidase. These findings support the potential of TAK-881 to deliver the required immunoglobulin (IG) dose for PID patients in half the volume of HYQVIA, reducing infusion duration while maintaining flexible, up to once-monthly dosing for patients (every three or four weeks for PID). The TAK-881-3001 clinical trial ev
Ouster Releases The REV8 OS Family: The World’s First Native Color Lidar4.5.2026 12:00:00 CEST | Press Release
Ouster, Inc. (Nasdaq: OUST) (“Ouster” or the “Company”), a leader in sensing and perception for Physical AI, announced today its new family of OS digital lidar sensors, Rev8, powered by its next-generation L4 Ouster Silicon. Ouster Rev8 features the world’s first patented native color lidar sensors, provides up to double the range and resolution of the previous generation, and is designed for functional safety, reliability, affordability, and scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260504718668/en/ The REV8 OS Family: The World's First Native Color Lidar. L4 Ouster Silicon: Ouster’s breakthrough L4 architecture doubles the range and resolution of its lidar over the prior generation, adds native-color sensing, and is designed for functional safety. Based on patented Ouster Silicon with embedded Fujifilm color science, the L4 chip results in exquisite color data and hardware-enabled HDR. It boasts 42.9 GMACs of p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom